控制IL7R分裂并增加多发性硬化症的风险
Gaddiel Galarza-Muñoz1, Farren B S Briggs2, Irina Evsyukova3
1Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA; Center for RNA Biology, Duke University, Durham, NC 27710, USA; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Cell
|March 25, 2017
概括
研究人员确定DDX39B是互白素-7受体α (IL7R) 拼接的关键调节者,影响多发性硬化症 (MS) 风险. 在DDX39B的基因变异通过影响IL7R外因子6剪接影响MS易感性.
科学领域:
- 神经免疫学
- 分子遗传学
- 自身免疫性疾病
背景情况:
- 多发性硬化 (MS) 是一种针对中枢神经系统 (CNS) 的自身免疫疾病.
- 增加的MS风险与可溶性IL-7受体α (sIL7R) 与IL7R外基子6的替代拼接有关.
- 多发性硬化病的遗传基础涉及复杂的相互作用和调节机制.
研究的目的:
- 确定IL7R外基子6剪接的新调节剂.
- 研究RNA螺旋酶DDX39B在多发性硬化病变中的作用.
- 阐明影响多发性硬化风险的遗传和功能相互作用.
主要方法:
- 核酸组合分析
- 遗传关联研究
- 基因变异的功能测试
- 表皮分析
主要成果:
- DDX39B被确定为IL7R外因子6的激活剂,从而抑制了sIL7R的产生.
- 在DDX39B的5' UTR的基因变异与DDX39B转化减少和MS风险增加有关.
- 在DDX39B变体和IL7R外基因6变体之间观察到显著的遗传和功能表皮.
结论:
- DDX39B作为IL7R外基子6拼接的关键调节者.
- 通过IL7R拼接的调节,DDX39B的遗传变异有助于MS风险.
- 这项研究证明了人类的生物学表现,为MS病因提供了机理性的洞察力.
相关概念视频
T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
RNA Splicing
61.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
Epistasis
50.7K
In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
50.7K
Epistasis Analysis
6.0K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
6.0K
Multiple Allele Traits
38.5K
The Concept of Multiple Allelism
38.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
71
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
71


